{"altmetric_id":1415688,"counts":{"readers":{"mendeley":14,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["HealthRead"],"posts_count":1}},"citation":{"abstract":"A phase II clinical trial previously evaluated the sequential administration of erlotinib after chemotherapy for advanced non-small-cell lung cancer (NSCLC). This current pilot study assessed the feasibility of sequential induction therapy in patients with stage IIB to IIIA NSCLC adenocarcinoma.","abstract_source":"pubmed","altmetric_jid":"4f6fa4d03cf058f6100008b8","doi":"10.1186\/1477-7819-11-96","first_seen_on":"2013-04-26T18:16:54+00:00","issns":["1477-7819"],"issue":"1","journal":"World Journal of Surgical Oncology","last_mentioned_on":1366999502,"links":["http:\/\/www.wjso.com\/content\/11\/1\/96\/abstract"],"pdf_url":"http:\/\/www.wjso.com\/content\/pdf\/1477-7819-11-96.pdf","pmid":"23621919","pubdate":"2013-04-26T00:00:00+00:00","publisher":"BioMed Central Ltd","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"96","subjects":["neoplasms","generalsurgery"],"title":"A pilot study: sequential gemcitabine\/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma","type":"article","volume":"11","mendeley_url":"http:\/\/www.mendeley.com\/research\/pilot-study-sequential-gemcitabinecisplatin-icotinib-induction-therapy-stage-iib-iiia-nonsmallcell-l"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":3632140,"mean":4.9249633348334,"rank":2740466,"this_scored_higher_than_pct":20,"this_scored_higher_than":733809,"rank_type":"exact","sample_size":3632140,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":84620,"mean":6.7076656542858,"rank":60556,"this_scored_higher_than_pct":22,"this_scored_higher_than":19038,"rank_type":"exact","sample_size":84620,"percentile":22},"this_journal":{"total_number_of_other_articles":916,"mean":1.6405202185792,"rank":565,"this_scored_higher_than_pct":10,"this_scored_higher_than":95,"rank_type":"exact","sample_size":916,"percentile":10},"similar_age_this_journal_3m":{"total_number_of_other_articles":39,"mean":1.2842105263158,"rank":15,"this_scored_higher_than_pct":12,"this_scored_higher_than":5,"rank_type":"exact","sample_size":39,"percentile":12}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Librarian":1,"Researcher":3,"Student  > Ph. D. Student":2,"Student  > Postgraduate":1,"Other":4,"Student  > Master":1,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":9,"Chemistry":1,"Psychology":1,"Computer Science":1,"Agricultural and Biological Sciences":1,"Unspecified":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/HealthRead\/status\/327845791345541121","license":"public","citation_ids":[1415688],"posted_on":"2013-04-26T18:05:02+00:00","author":{"name":"Health Research","image":"http:\/\/a0.twimg.com\/profile_images\/598569079\/med_normal.png","description":"Healthcare, medicine, pharmaceuticals, treatment, trends and interesting articles for today's technology savvy reader.","id_on_source":"HealthRead","tweeter_id":"100225709","geo":{"lt":38.89037,"ln":-77.031959,"country":"US"},"followers":17869},"tweet_id":"327845791345541121"}]}}